Although the delicate area around the eye is one of the first to show visible signs of aging, it is the eye contour in particular that is a concern to many consumers. NIOD (Non Invasive Options in Dermal Science) offers a Fractionated Eye Contour Concentrate that takes the form of a "hyper-concentrated bio-serum for the eye contour" that is packed with 28 clinical technologies to target issues.
The anti-aging treatment for both upper and lower eyelids offers a solution for everything from a loss of elasticity to fine lines, as well as dark circles, puffiness and uneven textures.
Some of the technologies that power the product include a Darutoside Complex, Full-Spectrum Fractions of Nature-Identical Hyaluronic Acid and the peptide technology peptide Methyl-Glucoside-6-Phosphate, also known as MG6P.
What's Driving This Trend
- Hydrating Bio-serums
- The rise in popularity of bio-serums packed with clinical technologies offers an opportunity for the beauty and skincare industry to innovate.
- Fractionated Eye Contour Concentrate
- The development of hyper-concentrated eye serums with multiple clinical technologies allows for new anti-aging and skincare product lines.
- Peptide Technology
- The use of peptide technology as an ingredient in skincare products is a growing trend that represents an opportunity for the beauty industry to differentiate its products.
Who This Affects Most
- Beauty and Skincare
- The beauty and skincare industry can capitalize on the trend of bio-serums and peptide technology to create innovative and effective anti-aging and skincare products.
- Pharmaceutical
- Pharmaceutical companies can leverage the development of bio-serums and peptide technology to create new medical and cosmetic products for treating skin conditions.
- Research and Development
- The rise in clinical technologies being used in bio-serums and skincare products presents an opportunity for research and development teams to innovate and create new treatments for various skin concerns.
